(245 days)
Not Found
No
The device description and performance studies focus on mechanical function and equivalence to predicate devices, with no mention of AI/ML capabilities or related data/training.
Yes
The device is described as an "hemorrhoidal ligator" used to "cut off the blood flow to hemorrhoidal tissue" by applying a ligature or ring. This action is intended to treat a medical condition (hemorrhoids), which aligns with the definition of a therapeutic device.
No
The "Intended Use" states that the device is "used to cut off the blood flow to hemorrhoidal tissue by means of a ligature or ring placed around the hemorrhoid base," indicating a therapeutic purpose rather than diagnostic.
No
The device description clearly outlines physical components (ligation unit, pusher, cone, trigger, cylindrical housing) and their mechanical function (pinching off hemorrhoidal nodule, releasing elastic band/ligature). There is no mention of software as a component or its function.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening.
- THD Bandy Function: The THD Bandy is a surgical device used directly on hemorrhoidal tissue within the body to cut off blood flow. It does not analyze specimens taken from the body.
The description clearly indicates it's a device for a surgical procedure, not for laboratory testing of samples.
N/A
Intended Use / Indications for Use
The THD Bandy is used to cut off the blood flow to hemorrhoidal tissue by means of a elastic band or a ligature placed around the hemorrhoid base.
The THD Bandy is to be used for exclusive use by medical personnel trained in proctology procedures.
Product codes (comma separated list FDA assigned to the subject device)
FHN
Device Description
The THD Bandy is an hemorthoidal ligator intended for pinching off hemorrhoidal nodule. The device is to be used in combination with a suction device, mounted on the basis of the THD Bandy. The THD Bandy consists of a ligation unit, a pusher and a cone. The ligation unit consists of a cylindrical housing connected with a trigger for the release of the elastic band or of the ligature. The hemorrhoidal nodule, trapped on the distal portion of the device, receive an elastic ring or a ligature in order to cut off the blood flow. The pusher and the cylindrical cone are provided in order to assist in the loading of the bands.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
hemorrhoidal tissue
Indicated Patient Age Range
Not Found
Intended User / Care Setting
medical personnel trained in proctology procedures
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance characteristics of device are equivalent to the Predicate Devices. The THD Bandy has been developed and tested according to the following international standards:
- V ISO 10993-1:2003, Biological evaluation of medical devices Part 1: Evaluation and testing. (Biocompatibility) - FDA Recognition Number 2-વેજ
- V CEN EN 980:1996+A1:1999+A2:2001, Graphical Symbols for Use in the Labelling of Medical Devices. - FDA Recognition Number 5-32
- V ISO 14971:2007, Medical devices Application of risk management to medical devices. (General) - FDA Recognition Number 5-40
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 876.4400 Hemorrhoidal ligator.
(a)
Identification. A hemorrhoidal ligator is a device used to cut off the blood flow to hemorrhoidal tissue by means of a ligature or band placed around the hemorrhoid.(b)
Classification. Class II (special controls). Except for a hemostatic metal clip intended for use in the gastrointestinal tract, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
THD S.p.A. 510(K) Notification
093497
page 1 of 2
THD Bandy
FDA CDRH DMC
1 1 5,20102010 Received
510(k) Summary for the THD Bandy
This 510(k) Summary is being submitted in accordance with the requirements of the SMDA 1990 and 21 CFR 807.92.
2.1. General Information
Submitter:
Contact Person:
THD S.p.A. Via dell'Industria, l 42015 - Correggio (RE) Italy
Guido Bonapace ISEMED srl Via Borgo Santa Cristina 12 40026 Imola (BO) Italy Mob.phone: +39-335-5378686 Telephone: +39-051-6527315 Fax: +39-0542 698456 Email: gbonapace@isemed.eu
Summary Preparation Date:
October 27, 2009
2.2. Names
Device Name: Classification Name: Product Code: Regulation number:
THD Bandy Hemorrhoidal ligator FHN 876.4400
2.3. Predicate Devices
The THD Bandy is substantially equivalent to the following devices:
| Applicant | Device name | 510(k) Number |
|---|---|---|
| Sapimed S.p.A. | LEM | K070881 |
| Haemoband Surgical | ||
| LTD | Haemoband Multi Ligator | K091519 |
| THD S.p.A. | THD Disposable | |
| Anoscope/Proctoscope | K080132 |
li
1
THD S.p.A. 510(K) Notification
K093497
page 2 of 2
THD Bandy
The THD Bandy is substantial equivalent to the predicate devices. The design characteristics are similar to the Sapimed model number A.5650 (LEM model for use with suction - K070881). The intended use of THD Bandy is the same as Sapimed LEM (K070881).
Both THD Bandy and Sapimed LEM (K070881) are manufacture in plastic material, are designed with similar dimensions and are single use devices. The THD Bandy is equivalent to the Sapimed LEM (K070881) and to the Haemoband Multi Ligator Device (K091519) and to the THD Disposable Anoscope/Proctoscope (K080132) concerning the labeling information.
2.4. Device Description
The THD Bandy is an hemorthoidal ligator intended for pinching off hemorrhoidal nodule. The device is to be used in combination with a suction device, mounted on the basis of the THD Bandy. The THD Bandy consists of a ligation unit, a pusher and a cone. The ligation unit consists of a cylindrical housing connected with a trigger for the release of the elastic band or of the ligature. The hemorrhoidal nodule, trapped on the distal portion of the device, receive an elastic ring or a ligature in order to cut off the blood flow. The pusher and the cylindrical cone are provided in order to assist in the loading of the bands.
2.5. Indications for Use
The THD Bandy is used to cut off the blood flow to hemorrhoidal tissue by means of a elastic band or a ligature placed around the hemorrhoid base.
The THD Bandy is to be used for exclusive use by medical personnel trained in proctology procedures.
2.6. Performance Data
Performance characteristics of device are equivalent to the Predicate Devices. The THD Bandy has been developed and tested according to the following international standards:
- V ISO 10993-1:2003, Biological evaluation of medical devices Part 1: Evaluation and testing. (Biocompatibility) - FDA Recognition Number 2-વેજ
- V CEN EN 980:1996+A1:1999+A2:2001, Graphical Symbols for Use in the Labelling of Medical Devices. - FDA Recognition Number 5-32
- V ISO 14971:2007, Medical devices Application of risk management to medical devices. (General) - FDA Recognition Number 5-40
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or a stylized human figure with outstretched arms. The symbol is composed of three thick, curved lines that converge at the bottom.
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
THD S.p.A c/o Mr. Guido Bonapace President and Regulatory Consultant ISEMED S.r.l. Via Borgo Santa Cristina 12 Imola, BO ITALY 40026
JUL 1 3 2010.
Re: K093497
Trade/Device Name: THD Bandy Regulation Number: 21 CFR §876.4400 Regulation Name: Hemorrhoidal ligator Regulatory Class: II Product Code: FHN Dated: July 5, 2010 Received: July 7, 2010
Dear Mr. Bonapace:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related
3
adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Janine M. Morris
Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
THD S.p.A. 510(K) Notification
THD Bandy
JUL 1 5 2010
Indications for Use
510(k) Number (if known): K093497
Device Name:
THD Bandy
Indications for Use:
The THD Bandy is used to cut off the blood flow to hemorrhoidal tissue by means of a ligature or ring placed around the hemorrhoid base.
The THD Bandy is to be used for exclusive use by medical personnel trained in a proctology procedures.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | |
|---|---|
| --------------------- | -- |
Division of Reproductive, Abdominal, and
Radiological Devices
| 510(k) Number | K093497 |
|---|---|
| --------------- | --------- |